Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07281391 · ClinicalTrials.gov registry record
IOP Reduction in Pigmentary Glaucoma Using DSLT
A clinical trial, sponsored by Mann Eye Institute.
- Recruiting
- Registry status
- 45
- Enrollment target
NCT07281391 is a clinical trial that is actively recruiting participants, run by Mann Eye Institute. The registered enrollment target is 45 participants.
The verdict
NCT07281391 is actively recruiting participants, sponsored by Mann Eye Institute.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
Study Summary
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Interventions
- DEVICE Voyager DSLT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-03-19 |
| Est. Completion | 2027-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07281391
The ClinicalTrials.gov registry entry for NCT07281391 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mann Eye Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voyager DSLT is the first listed.
NCT07281391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07281391 about?
NCT07281391 is a clinical study titled "IOP Reduction in Pigmentary Glaucoma Using DSLT". This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
What is the current status of trial NCT07281391?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2026-03-19. Estimated completion is 2027-04-01.
What interventions are being tested in trial NCT07281391?
The interventions under investigation include: Voyager DSLT (DEVICE).
Who is sponsoring clinical trial NCT07281391?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.